Superworth

Palatin Technologies EPS PTN

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.08
Latest quarter, Q4 FY26
−$1.11
Fiscal year 2026
−$0.08

Palatin Technologies' earnings per share was −$0.08 over the twelve months to Jun 30, 2026.

In its latest quarter, Q4 FY26, it was −$1.11.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2026−$0.08n/a
FY2025−$37.48n/a
FY2023−$110.50n/a
FY2022−$192.00n/a
FY2021−$175.00n/a
FY2020−$112.50−160%
FY2019$187.50+36%
FY2018$137.50n/a
FY2017−$112.50n/a
FY2016−$400.00n/a
FY2015−$150.00n/a
FY2014−$150.00n/a
FY2013−$312.50n/a
FY2012−$625.00n/a
FY2011−$925.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q4 FY26−$1.11n/a−$0.08
Q3 FY26−$0.37n/a−$1.69
Q2 FY26−$2.86n/a−$10.45
Q1 FY26$4.26n/a−$13.51
Q4 FY25−$2.72n/a−$37.48
Q3 FY25−$9.13n/an/a
Q2 FY25−$5.92n/an/a
Q1 FY25−$19.71n/an/a
Q3 FY24−$26.50n/a−$118.00
Q2 FY24−$28.00−324%−$129.50
Q1 FY24−$21.50n/a−$89.00
Q4 FY23−$42.00n/a−$110.50

Against its peers

Companies in Drug Manufacturers - General nearest Palatin Technologies' size, closest first, today.

CompanyEPS, 12 monthsGrowth
PTNPalatin Technologies−$0.08
ATNMActinium Pharmaceuticals$0.36
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
Peer median$0.36

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Palatin Technologies

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.